Radiotherapy: Beyond cancer…
Nicolas Giraud(Université Claude Bernard Lyon 1), Thomas Leroy(Centre Hospitalier de Valenciennes), Cyrus Chargari(Institut Gustave Roussy), Magali Quivrin(Centre Georges François Leclerc), Mickaël Andraud(Sorbonne Université), Abel Cordoba(Centre Oscar Lambret), Richard Shaffer(Bupa Cromwell Hospital), Cécile Ortholan(Princess Grace Hospital Centre)
Cited by 4
Related Papers
MRI-guided adaptive brachytherapy in locally advanced cervical cancer (EMBRACE-I): a multicentre prospective cohort study
|The Lancet Oncology|2021|624
Volumetric Modulated Arc Therapy for Delivery of Prostate Radiotherapy: Comparison With Intensity-Modulated Radiotherapy and Three-Dimensional Conformal Radiotherapy
|International Journal of Radiation Oncology*Biology*Physics|2008|532
Volumetric Modulated Arc Therapy Improves Dosimetry and Reduces Treatment Time Compared to Conventional Intensity-Modulated Radiotherapy for Locoregional Radiotherapy of Left-Sided Breast Cancer and Internal Mammary Nodes
|International Journal of Radiation Oncology*Biology*Physics|2009|365
Adding abiraterone or docetaxel to long-term hormone therapy for prostate cancer: directly randomised data from the STAMPEDE multi-arm, multi-stage platform protocol
|Annals of Oncology|2018|252
A Comparison of Volumetric Modulated Arc Therapy and Conventional Intensity-Modulated Radiotherapy for Frontal and Temporal High-Grade Gliomas
|International Journal of Radiation Oncology*Biology*Physics|2009|153